LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

MUBD‐DecoyMaker 2.0: A Python GUI Application to Generate Maximal Unbiased Benchmarking Data Sets for Virtual Drug Screening

Photo by campaign_creators from unsplash

Ligand enrichment assessment based on benchmarking data sets has become a necessity for the rational selection of the best‐suited approach for prospective data mining of drug‐like molecules. Up to now,… Click to show full abstract

Ligand enrichment assessment based on benchmarking data sets has become a necessity for the rational selection of the best‐suited approach for prospective data mining of drug‐like molecules. Up to now, a variety of benchmarking data sets had been generated and frequently used. Among them, MUBD‐HDACs from our prior research efforts was regarded as one of five state‐of‐the‐art benchmarks in 2017 by Frontiers in Pharmacology. This benchmarking set was generated by one of our unique de‐biasing algorithms. It also rendered quite a few other cases of successful applications in recent years, thus is expected to have more impact in modern drug discovery. To make our algorithm amenable to more users, we developed a Python GUI application called MUBD‐DecoyMaker 2.0. Moreover, it has two new additional functional modules, i. e. “Detect 2D Bias” and “Quality Control”. This new GUI version had been proved to be easy to use while generate benchmarking data sets of the same quality. MUBD‐DecoyMaker 2.0 is freely available at https://github.com/jwxia2014/MUBD‐DecoyMaker2.0, along with its manual and testcase.

Keywords: benchmarking data; data sets; drug; mubd decoymaker

Journal Title: Molecular Informatics
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.